Research study Program year 2023 Source: CMS Open Payments

Phase II dose finding PoCC in CKD

Research payments

$7,272,626

157 payments

Through program year 2023, $7,272,626 in research payments was reported against Phase II dose finding PoCC in CKD, across 157 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$3,922,680	38
2022	Research	$3,342,359	118
2021	Research	$7,587	1

Breakdown

Who paid Research payments · program years 2021–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $7,271,596 120 payments
Boehringer Ingelheim International GmbH $1,030 37 payments

Who received the money Research payments · program years 2021–2023

Pines Care Research Center LLC Organisation paid for research $1,405,629 2 payments
Carolina Clinical Research Organisation paid for research $1,296,770 2 payments
Elixia Research Organisation paid for research $1,025,082 3 payments
Elixia LLC Organisation paid for research $533,595 3 payments
San Marcus Research Clinic INC Organisation paid for research $520,945 4 payments
Total Research Group LLC Organisation paid for research $383,730 5 payments
Denver Nephrologists Pc Organisation paid for research $250,580 2 payments
Horizon Research Group LLC Organisation paid for research $191,409 5 payments
Clinical Research Of Brandon Organisation paid for research $152,378 4 payments
Valley Clinical Trials Organisation paid for research $151,510 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.